Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Opioid treatment of pain is generally safe with 0.5% or less events from respiratory depression. However, fatalities are regularly reported. The only treatment currently available to reverse opioid respiratory depression is by naloxone infusion. The efficacy of naloxone depends on its own pharmacological characteristics and on those (including receptor kinetics) of the opioid that needs reversal. Short elimination of naloxone and biophase equilibration half-lives and rapid receptor kinetics complicates reversal of high-affinity opioids. An opioid with high receptor affinity will require greater naloxone concentrations and/or a continuous infusion before reversal sets in compared with an opioid with lower receptor affinity. The clinical approach to severe opioid-induced respiratory depression is to titrate naloxone to effect and continue treatment by continuous infusion until chances for renarcotization have diminished. New approaches to prevent opioid respiratory depression without affecting analgesia have led to the experimental application of serotinine agonists, ampakines, and the antibiotic minocycline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As previously proposed for other potent opioids (Amaducci et al., 2023; Bilel et al., 2022; Dahan et al., 2010; Klebacher et al., 2017), repeated naloxone dosing may be required to avoid re-narcotization.”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Dahan et al., 2010
In the citing paper
“Changes in RR and BL were fully blocked after naloxone pretreatment for all analogues (excluding iodorphine), confirming the involvement of opioid receptors (particularly MOR) in these actions (Bilel et al., 2022; Dahan et al., 2010).”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Dahan et al., 2010
In the citing paper
“Hence, the potency and intrinsic efficacy of MOR agonists may influence the observed effects after naloxone pretreatment (Bilel et al., 2023; Dahan et al., 2010; Nakamura et al., 2020; van Lemmen et al., 2023; Volpe et al., 2011), as also seen with fentanyl analogues (Bilel et al., 2023, 2022; Varshneya et al., 2023).”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Dahan et al., 2010
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Pre-Bötzinger Complex: a Brainstem Region that May Generate Respiratory Rhythm in Mammals
Smith, J. C., Ellenberger, H. H., Ballanyi, K., Richter, D. W., & Feldman, J. L. (1991) · Science · doi:10.1126/science.1683005 · Cited by 2,175
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Looking for inspiration: new perspectives on respiratory rhythm
Feldman, J. L., & Del Negro, C. A. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1871 · Cited by 846
Opioids and the control of respiration
Pattinson, K. T. S. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen094 · Cited by 793 · cited 1×
“The inhibition of this dynamic respiratory control system by opioids has been reviewed recently.(70) Respiratory drive may be restored by manipulation of neuronal transmitter systems in those regions, particularly serotinergic systems.”
BackgroundIonotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788 · cited 3×
“collectively called ampakines, examples of which are CX516, CX546, CX614, and CX717.(96,101) The AMPA receptor is”
BackgroundRekling, J. C., & Feldman, J. L. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.385 · Cited by 583
Pronounced, Episodic Oxygen Desaturation in the Postoperative Period
Catley, D. M., Thornton, C., Jordan, C., Lehane, J. R., Royston, D., & Jones, J. G. (1985) · Anesthesiology · doi:10.1097/00000542-198507000-00004 · Cited by 426 · cited 2×
“Definitions of what levels may constitute respiratory depression, however, will vary between practices or studies (e.g., Catley et al.16 who used SpO2 level of 80%).”
MethodDistinct rhythm generators for inspiration and expiration in the juvenile rat
Janczewski, W. A., & Feldman, J. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.098848 · Cited by 403
Buprenorphine: A Review of its Pharmacological Properties and Therapeutic Efficacy
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1979) · Drugs · doi:10.2165/00003495-197917020-00001 · Cited by 398
Cited by
Poorly controlled postoperative pain: prevalence, consequences, and prevention
Gan, T. J. (2017) · Journal of Pain Research · doi:10.2147/jpr.s144066 · Cited by 1,489
Turner, P. V., Brabb, T., Pekow, C. A., & Vasbinder, M. A. (2011) · PubMed · Cited by 1,324
Hah, J. M., Bateman, B. T., Ratliff, J., Curtin, C., & Sun, E. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002458 · Cited by 728
A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs
Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000034 · Cited by 488
“Copyright C© 2014 American Society of Addiction Medicine ISSN: 1932-0620/14/0803-0153 DOI: 10.1097/ADM.0000000000000034 and prevents fatalities (Buajordet et al., 2004; Clarke et al., 2005; Dahan et al., 2010; Boyer, 2012).”
BackgroundInfluentialA review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Metadata
- Authors
- Dahan, A., Aarts, L., & Smith, T. W.
- Affiliations
- Leiden University Medical Center (NL)
- Clinical Pharmacologist, North Yorkshire, United Kingdom.
- ORCID
- Dahan, Albert
- Venue
- Anesthesiology
- Published
- 2010-01-01
- Volume
- 112
- Issue
- 1
- Pages
- 226-238
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2132468342
- Cited by
- 634
- References
- 114
- Citations by year
- 2026: 30 · 2025: 34 · 2024: 38 · 2023: 31 · 2022: 58 · 2021: 57 · 2020: 59 · 2019: 53 · 2018: 37 · 2017: 43 · 2016: 35 · 2015: 39 · 2014: 30 · 2013: 35 · 2012: 21
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesiology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid-induced respiratory depression, naloxone, naloxone reversal, opioid receptor affinity, receptor kinetics, opioid analgesia, serotonergic agonists, ampakines, minocycline
- MeSH terms
- Buprenorphine, Humans, Minocycline, Naloxone, Narcotic Antagonists, Postoperative Complications, Respiratory Insufficiency, Serotonin Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression. https://app.cochat.ai/papers/10.1097/aln.0b013e3181c38c25
- The paper
- Dahan, A., Aarts, L., & Smith, T. W. (2010). Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression. Anesthesiology. https://doi.org/10.1097/aln.0b013e3181c38c25
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.